Skip to Main

Search

Results 561 to 570 of 938 for ""

CRI scientists link hematopoietic cell transplant deaths to beta-blocker use: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2024/dec-beta-blocker.html

Patients can die if they take certain previously prescribed beta-blockers during a hematopoietic cell transplant due to suppressed signals from nerves that promote bone marrow regeneration.

UT Southwestern Q&A: What you need to know about the measles: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2025/march-qa-measles.html

The outbreak of measles that started in West Texas in January and spread to other regions and states has focused renewed attention on a childhood disease that had been eliminated in the United States in recent decades.

"Reelin" in a new treatment for multiple sclerosis: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2020/new-treatment-ms.html

In an animal model of multiple sclerosis (MS), decreasing the amount of a protein made in the liver significantly protected against development of the disease’s characteristic symptoms and promoted recovery in symptomatic animals, UTSW scientists report.

Newsroom Archive: 2026 - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2026/

Stories published in 2026 about UT Southwestern Medical Center.

Cause of ‘brain freeze’ a bit of a mystery, but not to worry: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2023/aug-brain-freeze.html

You’re eating or drinking something frozen, like a snow cone, ice cream, or ice pops – probably a bit too eagerly – and you get one of those sudden-onset, painful headaches known as “brain freeze.” Man, does it hurt, but usually not for long, and it’s not harmful, according to an expert at UT

Higher dose of semaglutide increases weight loss, metabolic benefits: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2025/sept-semaglutide.html

Tripling the standard dose of semaglutide, a popular drug prescribed to treat obesity, led to significantly greater weight loss and associated metabolic benefits without increased risk of serious side effects, a multicenter clinical trial led by a UT Southwestern Medical Center researcher shows.

Style for Journalists: Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/media-relations/style-for-journalists.html

Important information regarding journalistic and media representation of UT Southwestern.

The perfect match: UTSW students open envelopes to residency futures : Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2025/march-match-day.html

Members of UT Southwestern Medical School’s Class of 2025 gathered with anticipation inside the Bryan Williams, M.D., Student Center gymnasium Friday morning to learn where they will begin the next phase of their training as residents.

UTSW finds potential key to predict immunotherapy toxicity : Newsroom - UT Southwestern, Dallas, Texas

https://www.utsouthwestern.edu/newsroom/articles/year-2023/aug-immunotherapy-toxicity.html

Researchers at UT Southwestern Medical Center have identified a novel parameter of T cells that could help oncologists anticipate which patients would be most likely to develop immunotherapy toxicity.

UTSW Research: Diagnosing Alzheimer’s, timed radiation therapy, and more

https://www.utsouthwestern.edu/newsroom/articles/year-2025/sept-research-roundup.html

Studies look at measuring blood flow velocity, a treatment strategy for non-small cell lung cancer, and the body’s response to airborne pathogens.